Finally going through emails and came across this post from @urotoday urotoday.com/recent-abstract… this is an exciting paper for ptnts w/SRMs thanks @shanekronos @eric_facs and Dr. Eric Kauffman from @RoswellUrology & others for this impt work!
This is an impt consideration 4 ptnts diagnosed with a small renal mass. Often they're told that it'a anywhere frm 75-90% certain they have RCC Leading to lots of anxiety Usually they have surgery and only then find out they have a b9 tumor
While everyone seems to agree appropriate risk stratification of #renalmasses should be goal of imaging — we think #molecularimaging has key role to play. pubmed.ncbi.nlm.nih.gov/4253… @michael_gorin @gottsled @liljasolnes #KIRADS
Debra Gottsleben retweeted
Thank you to the amazing partners on this project! @TiansterZhang @DrVaishampayan @lisapic @AlbigesL @MichaelStaehler @spsutkaMD @d_shapiro1 @uretericbud @Cold_Steel_1970. And thanks to @OncoAlert for highlighting! Let’s talk about cure in #kidneycancer!
DAY Two of OncoAlert 🚨 Coverage of #IKCSEU26
Provider Perceptions of Cure in Renal Cell Cancer Presented by Ms. Dena Battle🇺🇸 of @kcCURE
RCC specialists demonstrate notable hesitancy in using the term “cure,” even in clinical contexts where long-term outcomes may justify it. This reluctance reflects not only clinical uncertainty but also parallels similar reservations among patients. The absence of a standardized definition contributes to inconsistent communication, potentially affecting expectations and decision-making. Establishing clearer, consensus-driven terminology around “cure” in RCC could enhance transparency, improve physician–patient alignment, and support more informed shared decision-making. Addressing this linguistic and conceptual gap may ultimately strengthen trust and facilitate more meaningful discussions about prognosis and treatment goals in renal cell carcinoma care. #KidneyCancer
@KidneyCancer Jean-Christophe Bernhard @univbordeaux @AlbigesL @gustaveroussy @TiansterZhang @Dr_SabyGeorge @ZakhariaYousef @ERPlimackMD @Ric_Campi @DrIacovelli @RebuzziSara @weoncologists @GEVaughan1 @salvolarosa @DrYukselUrun #KidneyCancer @daniyal_jafree @EJonasch @IKCCorg @sophiemerrick1 @BarbaraJereczek @ESTRO_RT @ZakhariaYousef @kuraoncology @Selcuk__Erdem @drulkav @RCCadvocate
Happy Birthday @MichaelStaehler!
Happy birthday, @MichaelStaehler! Thanks for always challenging us to reach higher - we’re better for it. I hope you and Dena have a fantastic celebration together!
Totally agree!
Replying to @gottsled
Thank you @gottsled. Hoping this will be a new era for renal mass #molecularimaging!
Very excited to see this research! So important for the many ptnts diagnosed with small renal mass
pubmed.ncbi.nlm.nih.gov/4106… #SNMMI #EANM #ACNM guideline for #molecularimaging of renal masses @BrianShuch @SNM_MI @UTSWMedCenter. Congrats to the committee!
Debra Gottsleben retweeted
I hear about this. This is not uncommon and it bothers me:
Patient has cancer which is getting worse and causing pain
Waits days for doctors appointment
See the doctor. Scans ordered.
But now waits days for an appointment slot to get the scans
Scan is done and shows the cancer has worsened. Doctor prescribes new treatment
Waits for days as insurance denies new treatment. Peer to peer call needed. Finally, treatment is approved.
Waits for days again because chemotherapy appointments are backed up.
Finally, the patient receives the treatment.
But a month has passed.
The cancer has progressed more.
All of this with good private insurance.
Imagine without.
Oncology has advanced rapidly. Our medicines are very specialized. They require a lot of time, expertise, resources. Oncologists are stretched thin. It’s not the type of work that you can easily fill without compromising care. Many patients receive complex chemo and when there is a complication they end up without access to specialized care. We need to expand the oncology work force and limit the burnout that is causing good oncologists to leave patient care for other jobs or retire.
There is no question we have made remarkable progress against cancer. And several promising new treatments are on the horizon. Will we have the resources to administer them safely and to all those who need it?
Debra Gottsleben retweeted
I am delighted and honored to join the great team @RushUrology @RushMedical I want to thank my colleagues @UCSDHealth and @UCSD_Urology #Chicago here I come! #KidneyCancer #UrologicOncology @UroOnc @AmerUrol @EECherullo @cjkane10
I just entered to win an awesome prize! ul.ink/M0RD2-QEA484_t Let's see if I actually win. Would be great seeing Sir Paul live and in person!
This is exciting news for ptnts with small renal masses!
Advancing the management of indeterminate renal masses: The emerging role of molecular imaging. @uretericbud @FoxChaseCancer joins @zklaassen_md @GACancerCenter in this conversation, highlighting exciting developments in molecular imaging, particularly the #ZIRCON trial's TLX250 carbonic anhydrase 9 PET scan. #WatchNow > bit.ly/4krm5Ul
I am so sorry
I loved reading his posts. I even got a few responses from him.
My condolences to the family.
The Skeptical Scalpel passed away on June 19th, 2025. He died peacefully in his home surrounded by his loving family. You can read about a remarkable man's life well lived here (thegreencremation.com/obitua…) . He will be missed by all who knew him.
Debra Gottsleben retweeted
Look at some of the impact of DOD CDMRP funding. @BraunMDPhD is presenting the personalized vaccine in RCC published in @Nature.
Please restore funding. It went from $50 Million to $0 Dollars. We have not solved cancer yet!
@kidneycan #KCRS25
Debra Gottsleben retweeted
Only mug that felt right this morning. Four years ago today, this place saved my life after a rare stage IV cancer at 29, threatened to steal my future.
We must continue to support cancer research so more patients have the opportunity to celebrate these beautiful milestones.
Debra Gottsleben retweeted
Patient Perspectives are essential to any field in medicine & @AmerUrological made sure to include them as a part of #AUA25. Watch now as we catch up with several of the patients who brought their insights to the meeting. @bladderexstroph @notaspare_kcadv youtu.be/2ve4FRh6_Ho
Debra Gottsleben retweeted
Four years ago Dr. Hernandez was visiting me on rounds after a stage IV dx at 29 led to Hail Mary of a surgery to give me a shot at a future. Fast forward a few years and we’ve upgraded to him visiting me at my poster instead #AACR25.